GO:0001936 regulation of endothelial cell proliferation: Signaling Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001936 describes any biological process that modulates the frequency, rate, or extent of endothelial cell proliferation, a central event in angiogenesis and vascular homeostasis.
• Endothelial cell proliferation is controlled by a balance of pro- and anti-proliferative signals, including NOTCH, VEGF, HIF-1α, and cell-cycle regulators such as ATF-2 and Tpl2.
• Dysregulation of endothelial proliferation contributes to cardiovascular disease, tumor angiogenesis, and chronic inflammatory conditions.
• Key experimental models include zebrafish flow-responsive screens, endothelial cell culture, and single-cell transcriptomics.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate regulators in endothelial cells.
• Understanding GO:0001936 supports development of anti-angiogenic therapies and vascular regeneration strategies.
Description
Regulation of endothelial cell proliferation (GO:0001936) is a fundamental biological process that governs the expansion of endothelial cells, the cells lining the inner surface of blood vessels. This process is essential for angiogenesis, vascular repair, and maintenance of vascular homeostasis, and its dysregulation is implicated in numerous pathological conditions including cancer, cardiovascular disease, and chronic inflammation. Endothelial cell proliferation is tightly controlled by a complex network of signaling pathways, transcription factors, and cell-cycle regulators that respond to both biochemical and mechanical cues. Researchers studying vascular biology, tumor angiogenesis, and regenerative medicine require a precise understanding of how this process is modulated at the molecular level. The integration of CRISPR-based genome editing with advanced screening technologies has accelerated the discovery of novel regulators of endothelial proliferation, offering new opportunities for therapeutic intervention.
regulation of endothelial cell proliferation At A Glance
| GO ID | GO:0001936 |
|---|---|
| GO term | regulation of endothelial cell proliferation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate, or extent of endothelial cell proliferation |
| Related processes | Angiogenesis, vascular development, cell cycle regulation |
| Key signaling pathways | NOTCH, VEGF, HIF-1α, ATF-2/Tpl2 |
| Disease relevance | Cancer, cardiovascular disease, inflammation |
What Is GO:0001936?
GO:0001936, regulation of endothelial cell proliferation, is defined as any process that modulates the frequency, rate, or extent of endothelial cell proliferation. This encompasses both positive and negative regulatory mechanisms that control the entry, progression, and exit of endothelial cells from the cell cycle, thereby determining the size and functional capacity of endothelial cell populations in blood vessels.
Why Is regulation of endothelial cell proliferation Important in Cell Biology?
Regulation of endothelial cell proliferation is critical for normal vascular development and tissue repair, but its dysregulation drives pathological angiogenesis in tumors, atherosclerotic plaques, and inflammatory diseases. Understanding the molecular mechanisms that control endothelial proliferation provides a foundation for developing targeted therapies that either promote vascular regeneration or inhibit aberrant blood vessel growth.
• Controls angiogenesis, the formation of new blood vessels from existing ones.
• Essential for embryonic vascular development and organogenesis.
• Dysregulated in tumor angiogenesis, supporting cancer growth and metastasis.
• Plays a role in atherosclerosis and plaque neovascularization.
• Involved in wound healing and tissue regeneration.
• Modulated by mechanical forces such as shear stress.
• Target for anti-angiogenic therapies in oncology and ophthalmology.
• Key area for vascular tissue engineering and regenerative medicine.
• Regulated by epigenetic modifications including RNA m6A methylation.
• Provides a model for studying cell-cycle control and senescence.
What Happens During regulation of endothelial cell proliferation?
Initiation of proliferative signals
In simple terms: Endothelial cells receive signals that tell them to start dividing.
Endothelial cell proliferation is initiated by growth factors such as VEGF and by mechanical cues like shear stress. These signals activate receptors and downstream pathways that promote entry into the cell cycle. For example, HIF-1α/VEGF signaling is a key driver of endothelial proliferation under hypoxic conditions. Flow-responsive genes also play a critical role in initiating proliferation in response to blood flow.
Cell cycle progression
In simple terms: Once told to divide, cells go through the steps of the cell cycle.
After receiving proliferative signals, endothelial cells progress through the G1/S transition and complete mitosis. This progression is regulated by cyclins, cyclin-dependent kinases, and transcription factors such as ATF-2 and Tpl2, which control the expression of cell cycle-related genes and apoptosis. NOTCH signaling modulates the endothelial phenotype and can influence cell cycle entry.
Modulation by NOTCH and other signaling pathways
In simple terms: NOTCH and other pathways act as brakes or accelerators on cell division.
NOTCH signaling is a key regulator of endothelial cell phenotype and proliferation, often acting to limit excessive proliferation and promote quiescence in certain contexts. Other pathways, such as those involving CD34, can influence immune cell responses and indirectly affect the endothelial proliferative environment. RNA m6A modifications also contribute to cell-type-specific regulation of endothelial proliferation in atherosclerosis.
Senescence and apoptosis counterbalance
In simple terms: Cells can stop dividing or die, balancing proliferation.
Endothelial cell proliferation is counterbalanced by senescence and apoptosis. AQP1 has been shown to differentially orchestrate endothelial cell senescence, thereby influencing the proliferative capacity of the endothelium. Apoptosis, regulated by factors such as ATF-2 and Tpl2, also limits endothelial cell numbers. Catalpol, a natural compound, regulates apoptosis and proliferation of endothelial cells via the HIF-1α/VEGF pathway.
Key Genes Involved in GO:0001936 regulation of endothelial cell proliferation
The following genes and proteins are key regulators of endothelial cell proliferation, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NOTCH1 | Regulates endothelial cell phenotype and proliferation | Modulates angiogenic sprouting and quiescence |
| VEGFA | Promotes endothelial cell proliferation and angiogenesis | Target in anti-angiogenic therapy |
| HIF1A | Transcription factor driving VEGF expression under hypoxia | Regulates proliferation in ischemic tissues |
| ATF2 | Transcription factor controlling cell cycle and apoptosis | Modulates endothelial proliferation and survival |
| TPL2 | Kinase regulating ATF-2 activity and cell cycle | Influences endothelial cell cycle progression |
| CD34 | Surface marker and regulator of immune cell response | Affects endothelial-immune interactions |
| AQP1 | Water channel involved in senescence | Differentially orchestrates endothelial senescence |
| METTL3 | RNA m6A methyltransferase | Cell-type-specific roles in atherosclerosis |
| YTHDF1 | m6A reader protein | Modulates RNA fate in endothelial cells |
| PECAM1 | Endothelial cell adhesion molecule | Marker of endothelial identity and proliferation |
| CDH5 | VE-cadherin, endothelial junction protein | Maintains endothelial barrier and proliferation |
| KDR | VEGFR2, receptor for VEGF | Mediates proliferative signals |
| FLT1 | VEGFR1, decoy receptor for VEGF | Modulates VEGF availability |
| ETS1 | Transcription factor in endothelial development | Regulates angiogenic gene expression |
| SOX17 | Transcription factor for endothelial differentiation | Controls endothelial cell fate |
| CDKN1A | p21, cell cycle inhibitor | Limits endothelial proliferation |
| CCND1 | Cyclin D1, cell cycle promoter | Drives G1/S transition |
How Is regulation of endothelial cell proliferation Regulated?
Regulation of endothelial cell proliferation is controlled by multiple layers of molecular regulation. NOTCH signaling acts as a key modulator, often limiting excessive proliferation and promoting quiescence. The ATF-2/Tpl2 pathway regulates cell cycle progression and apoptosis in endothelial cells. Hypoxia-inducible factor 1 alpha (HIF-1α) drives VEGF expression, which in turn stimulates proliferation. Mechanical forces such as shear stress regulate flow-responsive genes that control endothelial proliferation. Additionally, RNA m6A modifications provide an epigenetic layer of regulation that is cell-type-specific in atherosclerosis. Senescence pathways, including those involving AQP1, counterbalance proliferative signals.
regulation of endothelial cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| VEGFA | Tumor angiogenesis | Xenograft mouse models, endothelial cell co-culture |
| NOTCH1 | Cardiovascular disease, cancer | Zebrafish, mouse knockout |
| HIF1A | Ischemic cardiovascular disease | Hypoxia chamber, endothelial cell culture |
| METTL3 | Atherosclerosis | Single-cell RNA-seq, knockout mice |
| AQP1 | Vascular aging | Senescence models, AQP1 knockout |
Cancer and tumor angiogenesis
Dysregulated endothelial cell proliferation is a hallmark of tumor angiogenesis, where endothelial cells proliferate excessively to form new blood vessels that supply the growing tumor. Targeting regulators of endothelial proliferation, such as VEGF and NOTCH, is a major therapeutic strategy in oncology. Single-cell studies have revealed cell-type-specific roles of RNA m6A modification in atherosclerosis, which shares some angiogenic features with tumors.
Cardiovascular disease
In cardiovascular diseases such as atherosclerosis, endothelial cell proliferation contributes to plaque neovascularization and instability. RNA m6A modification has been implicated in cell-type-specific functional roles in atherosclerosis, affecting endothelial proliferation. Endothelial differentiation and proliferation are also critical for embryonic vascular development, and their dysregulation can lead to congenital cardiovascular defects.
Inflammation and immune response
Endothelial cells interact with immune cells, and CD34 expression on endothelial cells regulates immune cell responses in vitro, which can influence inflammatory processes and endothelial proliferation. Chronic inflammation often leads to aberrant endothelial proliferation, contributing to diseases such as rheumatoid arthritis and inflammatory bowel disease.
Senescence and aging
Endothelial cell senescence is a key contributor to vascular aging and age-related diseases. AQP1 differentially orchestrates endothelial cell senescence, thereby affecting proliferative capacity and vascular health. Understanding the balance between proliferation and senescence is crucial for developing therapies for age-related vascular dysfunction.
From regulation of endothelial cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate endothelial proliferation? | CRISPR knockout in HUVECs or zebrafish |
| What is the effect of a point mutation in gene Y? | CRISPR point mutation knock-in in endothelial cells |
| How does gene Z overexpression affect proliferation? | Lentiviral overexpression in endothelial cells |
| What is the role of gene W in flow-responsive proliferation? | Zebrafish flow-responsive screening |
| How does gene V affect endothelial senescence? | CRISPR knockout and senescence assays |
| What is the cell-type-specific function of gene U? | Single-cell RNA-seq in atherosclerosis models |
How to Study the regulation of endothelial cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene function loss | Identify regulators of endothelial proliferation |
| RNA-seq | Transcriptome changes | Profile gene expression during proliferation |
| MeRIP-seq | RNA m6A modification | Epitranscriptomic regulation in atherosclerosis |
| EdU incorporation | DNA synthesis | Measure proliferation rate |
| Annexin V staining | Apoptosis | Assess cell death |
| Senescence-associated beta-galactosidase | Senescence | Evaluate endothelial aging |
| Zebrafish flow-responsive screen | In vivo proliferation | Functional screening of flow genes |
| Single-cell RNA-seq | Cell-type-specific expression | Uncover heterogeneity in atherosclerosis |
CRISPR screening for regulators
Genome-wide CRISPR knockout or activation screens in endothelial cells can identify novel regulators of proliferation. Zebrafish models enable functional screening of flow-responsive genes controlling endothelial cell proliferation. These screens can be combined with single-cell transcriptomics to reveal cell-type-specific functions.
Transcriptomic and epitranscriptomic profiling
RNA sequencing and single-cell RNA-seq can uncover gene expression changes during endothelial proliferation. RNA m6A modification can be profiled using MeRIP-seq to understand epitranscriptomic regulation in atherosclerosis. These methods help identify pathways and gene networks controlling proliferation.
Cell cycle and proliferation assays
EdU incorporation, Ki-67 staining, and flow cytometry are standard methods to measure endothelial cell proliferation. Apoptosis can be assessed by Annexin V staining or caspase activity assays. Senescence can be evaluated using beta-galactosidase staining.
Imaging and functional assays
Live-cell imaging and immunofluorescence can visualize endothelial cell division and tube formation. Zebrafish models allow real-time observation of endothelial proliferation in vivo. These assays are critical for validating findings from high-throughput screens.
How CRISPR Can Be Used to Study GO:0001936 regulation of endothelial cell proliferation
Knockout
CRISPR knockout of candidate genes in endothelial cells can determine whether they are necessary for proliferation. For example, knocking out ATF-2 or Tpl2 can reveal their roles in cell cycle progression and apoptosis. Zebrafish knockout models enable in vivo validation of flow-responsive genes.
Point Mutation
CRISPR point mutation knock-in can model specific amino acid changes in genes such as NOTCH1 or VEGFA to study their impact on endothelial proliferation. This approach is useful for dissecting signaling domains and phosphorylation sites.
Knock-in
Knock-in of reporter genes or tags (e.g., GFP) into endogenous loci allows real-time monitoring of endothelial proliferation. Tagged knock-in of cell cycle regulators can facilitate live-cell imaging and protein interaction studies.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can drive high expression of genes like HIF1A or VEGFA to study their effects on endothelial proliferation. Overexpression models are valuable for testing gain-of-function hypotheses.
How EDITGENE Supports regulation of endothelial cell proliferation Research
Researchers studying regulation of endothelial cell proliferation-related genes often need to determine whether a candidate gene is causally involved in the process. EDITGENE provides comprehensive CRISPR-based services to enable such investigations, from knockout to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for regulation of endothelial cell proliferation research.
Frequently Asked Questions About regulation of endothelial cell proliferation
What is GO:0001936?
GO:0001936 is the Gene Ontology term for regulation of endothelial cell proliferation, defined as any process that modulates the frequency, rate, or extent of endothelial cell proliferation.
What genes are involved in regulation of endothelial cell proliferation?
Key genes include NOTCH1, VEGFA, HIF1A, ATF2, TPL2, CD34, AQP1, and METTL3, among others.
How is endothelial cell proliferation regulated?
It is regulated by signaling pathways such as NOTCH, VEGF, HIF-1α, and ATF-2/Tpl2, as well as by mechanical forces and epigenetic modifications.
Why is regulation of endothelial cell proliferation important?
It is crucial for angiogenesis, vascular development, and tissue repair, and its dysregulation contributes to cancer, cardiovascular disease, and inflammation.
What diseases are associated with dysregulated endothelial cell proliferation?
Cancer, atherosclerosis, cardiovascular disease, and age-related vascular dysfunction are associated with abnormal endothelial proliferation.
How can I study regulation of endothelial cell proliferation?
You can use CRISPR knockout screens, RNA-seq, single-cell transcriptomics, and zebrafish models to study this process.
What is the role of NOTCH in endothelial cell proliferation?
NOTCH signaling regulates endothelial cell phenotype and often acts to limit excessive proliferation and promote quiescence.
How does hypoxia affect endothelial cell proliferation?
Hypoxia stabilizes HIF-1α, which drives VEGF expression and promotes endothelial cell proliferation.
What is the role of RNA m6A modification in endothelial proliferation?
RNA m6A modification has cell-type-specific functional roles in atherosclerosis and can influence endothelial cell proliferation.
Can CRISPR be used to study endothelial cell proliferation?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect gene function in endothelial proliferation.
Conclusion
Regulation of endothelial cell proliferation (GO:0001936) is a central biological process that controls vascular growth and homeostasis. Its dysregulation underlies numerous diseases, making it a prime target for therapeutic intervention. Advances in CRISPR genome editing and high-throughput screening have greatly expanded our understanding of the molecular players involved, offering new avenues for drug discovery and regenerative medicine.
References
- 1. Arakelian L et al.. 2023. Endothelial CD34 expression and regulation of immune cell response in-vitro.. Sci Rep 13(1):13512 PMID: 37598252
- 2. Shabanian K et al.. 2024. AQP1 differentially orchestrates endothelial cell senescence.. Redox Biol 76:103317 PMID: 39180980
- 3. Mack JJ et al.. 2018. NOTCH regulation of the endothelial cell phenotype.. Curr Opin Hematol 25(3):212-218 PMID: 29547401
- 4. Ping X et al.. 2025. Deciphering single-cell landscape unravels cell-type-specific functional roles of RNA m(6)A modification in atherosclerosis.. Theranostics 15(10):4785-4807 PMID: 40225569
- 5. Fearnley GW et al.. 2020. ATF-2 and Tpl2 regulation of endothelial cell cycle progression and apoptosis.. Cell Signal 66:109481 PMID: 31760171
- 6. Guo Z et al.. 2021. Regulation of endothelial cell differentiation in embryonic vascular development and its therapeutic potential in cardiovascular diseases.. Life Sci 276:119406 PMID: 33785330
- 7. Ni J et al.. 2024. Catalpol regulates apoptosis and proliferation of endothelial cell via activating HIF-1α/VEGF signaling pathway.. Sci Rep 14(1):28327 PMID: 39550364
- 8. Bowley G et al.. 2024. Zebrafish model for functional screening of flow-responsive genes controlling endothelial cell proliferation.. Sci Rep 14(1):30130 PMID: 39627337
